Skip to main content
eScholarship
Open Access Publications from the University of California

UC Riverside

UC Riverside Electronic Theses and Dissertations bannerUC Riverside

Mechanical Control of Retinal Vascular Inflammation in Diabetes

Abstract

The goal of this research was to understand the role of cell- and subendothelial matrix-dependent mechanical cues in retinal endothelial cell (EC) activation associated with diabetes and to identify novel molecular targets for effective suppression of diabetic retinal EC activation. Endothelial activation is a hallmark of high glucose (HG)-induced retinal inflammation associated with diabetic retinopathy. Here I identified that HG-induced upregulation of lysyl oxidase (LOX), a collagen-crosslinking enzyme, in retinal capillary endothelial cells (ECs) leads to subendothelial matrix stiffening that, in turn, promotes retinal EC activation. Further, I showed that (i) HG-induced subendothelial matrix stiffening significantly impairs Transient Receptor Potential Vanilloid 4 (TRPV4, a mechanosensitive Ca2+ channel) expression and activity, (ii) TRPV4 impairment alone is sufficient to promote high glucose-induced retinal EC activation, (iii) LOX inhibition prevents high glucose-induced impairment of TRPV4 and, consequently, anti-inflammatory nitric oxide. Finally, I showed that the inhibitory effect of matrix stiffening on TRPV4 is mediated, at least in part, via the canonical Rho/ROCK mechanotransduction pathway that directly controls EC stiffness. Together, these findings identify a crucial role of Rho/ROCK-mediated TRPV4 signaling in diabetic retinal EC activation and implicate Rho/ROCK and TRPV4 as the novel anti-inflammatory target for management of early DR.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View